ホーム › 急性骨髄性白血病 › ニューヨーク › Queens
Queens、NYにおける急性骨髄性白血病の臨床試験
Queensとその周辺地域（約30マイル以内）の拠点で、急性骨髄性白血病に関する21件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Queens Hospital Center, Jamaica · 2マイル先
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
被験者募集中第1相
- Memorial Sloan Kettering Nassau, Uniondale · 13マイル先
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Memorial Sloan Kettering Nassau, Uniondale · 13マイル先
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
被験者募集中第2相
- Northwell Health/Center for Advanced Medicine, Lake Success · 9マイル先
- Memorial Sloan Kettering Nassau, Uniondale · 13マイル先
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Northwell Health/Center for Advanced Medicine, Lake Success · 9マイル先
A Study of CRD3874-SI in People With Leukemia
被験者募集中第1相
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10マイル先
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Memorial Sloan Kettering Nassau, Uniondale · 13マイル先
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Northwell Health/Center for Advanced Medicine, Lake Success · 9マイル先
- Memorial Sloan Kettering Nassau, Uniondale · 13マイル先
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
被験者募集中第3相
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9マイル先
- NYU Langone Hospital - Long Island, Mineola · 11マイル先
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
被験者募集中第2相
- Clinical Research Allicance, Westbury · 14マイル先
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
被験者募集中第1/2相
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9マイル先
- NYU Langone Hospital - Long Island, Mineola · 11マイル先
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
被験者募集中第3相
- Cohen Children's Medical Center, Queens
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
被験者募集中第1相
- Northwell Health, LLC PRIME, Lake Success · 9マイル先
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
被験者募集中第2相
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10マイル先
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
被験者募集中第1相
- Memorial Sloan Kettering Nassau, Uniondale · 13マイル先
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
被験者募集中第1相
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10マイル先
A Study of Revumenib and Mezigdomide in People With Leukemia
被験者募集中第1/2相
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10マイル先
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
被験者募集中第1相
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10マイル先
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
被験者募集中第2/3相
- New York University Langone Hospital - Long Island, Mineola · 11マイル先
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
被験者募集中第1相
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13マイル先
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
被験者募集中第2相
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10マイル先
他の都市における急性骨髄性白血病の試験
- Houston, TX85件の研究
- New York City, NY51件の研究
- Boston, MA44件の研究
- Baldwin Park, CA40件の研究
- Seattle, WA40件の研究
- Columbus, OH35件の研究
- Philadelphia, PA34件の研究
- Durham, NC33件の研究
- Atlanta, GA30件の研究
- Tampa, FL29件の研究
- Chicago, IL26件の研究
- Portland, OR25件の研究
Queensにおける他の研究
- 乳がん63件の研究
- 非小細胞肺癌49件の研究
- 大腸癌31件の研究
- 転移性癌28件の研究
- 卵巣がん28件の研究
- 前立腺がん27件の研究
- がん（全種類）26件の研究
- 子宮内膜がん25件の研究
- 肺がん22件の研究
- 頭頸部扁平上皮癌20件の研究
- 多発性骨髄腫20件の研究
- 膵臓がん20件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。